(Q46908344)

26 December 2017

title

Surgical and biologic outcomes after neoadjuvant bicalutamide treatment in prostate cancer (English)

1 reference

26 December 2017

1 reference

Giovanni Luca Gravina

1

1 reference

26 December 2017

Adriano Angelucci

5

1 reference

26 December 2017

Giuseppe Paradiso Galatioto

Giuseppe Paradiso Galatioto

3

0 references

Mauro Bologna

Mauro Bologna

8

0 references

Carlo Vicentini

Carlo Vicentini

9

0 references

Paola Muzi

4

Paola Muzi

1 reference

26 December 2017

Claudio Festuccia

2

Claudio Festuccia

1 reference

26 December 2017

Piero Ronchi

6

Piero Ronchi

1 reference

26 December 2017

author name string

Alessia Mariagrazia Costa

7

1 reference

26 December 2017

language of work or name

English

0 references

publication date

1 October 2007

1 reference

26 December 2017

published in

Urology

1 reference

26 December 2017

volume

70

1 reference

26 December 2017

issue

4

1 reference

26 December 2017

page(s)

728-733

1 reference

26 December 2017

Effects of complete androgen blockade for 12 and 24 weeks on the pathological stage and resection margin status of prostate cancer

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.05.024

Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.05.024

Neoadjuvant therapy before radical prostatectomy: where have we been? Where are we going?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.05.024

The HER receptor family: a rich target for therapeutic development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.05.024

Targeting the HER-kinase axis in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.05.024

A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.05.024

Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.05.024

The ErbB receptors and their role in cancer progression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.05.024

Evaluating prostate needle biopsy: therapeutic and prognostic importance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.05.024

Elevated serum Her-2/neu level predicts decreased response to hormone therapy in metastatic breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.05.024

The role of HER1-HER4 and EGFRvIII in hormone-refractory prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.05.024

Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.05.024

Beneficial effect of combination hormonal therapy administered prior and following external beam radiation therapy in localized prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.05.024

The efficacy and sequencing of a short course of androgen suppression on freedom from biochemical failure when administered with radiation therapy for T2-T3 prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.05.024

Neoadjuvant androgen ablation prior to radiotherapy for prostate cancer: reducing the potential morbidity of therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.05.024

The HER2 extracellular domain as a prognostic and predictive factor in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.05.024

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.UROLOGY.2007.05.024

1 reference

26 December 2017

1 reference

26 December 2017